Stocks and Investing Stocks and Investing
Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023

Prakhar Agrawal Initiated (AKRO) at Buy and Held Target at $69 on, Sep 19th, 2023


Published on 2024-10-28 06:28:56 - WOPRAI, Prakhar Agrawal
  Print publication without navigation


Prakhar Agrawal of Cantor Fitzgerald, Initiated "Akero Therapeutics, Inc." (AKRO) at Buy and Held Target at $69 on, Sep 19th, 2023.

Prakhar has made no other calls on AKRO in the last 4 months.



There are 5 other peers that have a rating on AKRO. Out of the 5 peers that are also analyzing AKRO, 0 agree with Prakhar's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Prakhar


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $60 on, Wednesday, September 13th, 2023
  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $62 on, Tuesday, September 5th, 2023
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Monday, June 12th, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Wednesday, June 7th, 2023